BioKDE: Biomedical Knowledge Discovery Engine
Login
Signup
Scientific Articles
Patents
>
Search
Searching
Sorted by:
Relevance
Publication date
Citation
Download the report
×
Format:
PMID
Text
CSV
Selected Articles
×
Export
Add New
PMID
Title
Actions
Confirm Save
×
Name
Comment
Results by Year
Article Type
Clinical Trial
Meta-Analysis
Randomized Controlled Trial
Review
Systematic Review
Publication date
1 year
5 year
10 year
Custom range
Start Date:
End Date:
Reset all filters
399,474 results (0.036 seconds)
Clear Selection
Breast
cancer
in China.
Lei Fan,
Kathrin Strasser-Weippl,
+6 authors,
Jun-Jie Li,
Jessica St Louis,
Dianne M Finkelstein,
Ke-Da Yu,
Wan-Qing Chen,
Zhi-Ming Shao,
Paul E Goss.
less
Lancet Oncol. 2014 May 30; 15(7):e279-89. PMID: 24872111
Highly Cited. Review.
Cancer
-associated adipocytes: key players in
breast
cancer
progression.
Qi Wu,
Bei Li,
+3 authors,
Zhiyu Li,
Juanjuan Li,
Si Sun,
Shengrong Sun.
less
J Hematol Oncol. 2019 Sep 10; 12(1):95. PMID: 31500658
Free PMC article
Highly Cited. Review.
Targeting the PI3-kinase pathway in triple-negative
breast
cancer
.
J Pascual, N C Turner.
Ann Oncol. 2019 May 06; 30(7):1051-1060. PMID: 31050709
Highly Cited. Review.
Treatment landscape of triple-negative
breast
cancer
- expanded options, evolving needs.
Giampaolo Bianchini, Carmine De Angelis, Luca Licata, Luca Gianni.
Nat Rev Clin Oncol. 2021 Nov 09; 19(2):91-113. PMID: 34754128
Review.
Improving Outcomes for High-Risk Hormone Receptor-Positive
Breast
Cancer
With CDK Inhibition.
David Hicks, Ruth M O'Regan.
J Clin Oncol. 2022 Feb 24; 40(11):1142-1146. PMID: 35201844
Review.
The extracellular matrix in
breast
cancer
.
Jacob Insua-Rodríguez, Thordur Oskarsson.
Adv Drug Deliv Rev. 2015 Dec 30; 97:41-55. PMID: 26743193
Highly Cited. Review.
Targeting
Cancer
Stem Cells in Triple-Negative
Breast
Cancer
.
So-Yeon Park, Jang-Hyun Choi, Jeong-Seok Nam.
Cancers (Basel). 2019 Jul 09; 11(7):. PMID: 31324052
Free PMC article
Highly Cited. Review.
The Great Immune Escape: Understanding the Divergent Immune Response in
Breast
Cancer
Subtypes.
Sayali S Onkar,
Neil M Carleton,
+4 authors,
Peter C Lucas,
Tullia C Bruno,
Adrian V Lee,
Dario A A Vignali,
Steffi Oesterreich.
less
Cancer Discov. 2023 Jan 10; 13(1):23-40. PMID: 36620880
Free PMC article
Review.
Prospective Surveillance for
Breast
Cancer
-Related Arm Lymphedema: A Systematic Review and Meta-Analysis.
Bolette S Rafn, Jan Christensen, Anders Larsen, Kira Bloomquist.
J Clin Oncol. 2022 Jan 25; 40(9):1009-1026. PMID: 35077194
Systematic Review. Review.
Targeting the RB-E2F pathway in
breast
cancer
.
J Johnson,
B Thijssen,
+3 authors,
U McDermott,
M Garnett,
L F A Wessels,
R Bernards.
less
Oncogene. 2016 Feb 29; 35(37):4829-35. PMID: 26923330
Free PMC article
Highly Cited. Review.
Metabolic Reprogramming in
Breast
Cancer
and Its Therapeutic Implications.
Nishant Gandhi, Gokul M Das.
Cells. 2019 Jan 26; 8(2):. PMID: 30691108
Free PMC article
Highly Cited. Review.
Triple-negative
breast
cancer
: therapeutic options.
Susan Cleator, Wolfgang Heller, R Charles Coombes.
Lancet Oncol. 2007 Mar 03; 8(3):235-44. PMID: 17329194
Highly Cited. Review.
Clinical management of
breast
cancer
heterogeneity.
Dimitrios Zardavas, Alexandre Irrthum, Charles Swanton, Martine Piccart.
Nat Rev Clin Oncol. 2015 Apr 21; 12(7):381-94. PMID: 25895611
Highly Cited. Review.
Aiming at a Tailored Cure for ERBB2-Positive Metastatic
Breast
Cancer
: A Review.
Paolo Tarantino,
Giuseppe Curigliano,
+6 authors,
Heather A Parsons,
Nancy U Lin,
Ian Krop,
Elizabeth A Mittendorf,
Adrienne Waks,
Eric P Winer,
Sara M Tolaney.
less
JAMA Oncol. 2022 Jan 14; 8(4):629-635. PMID: 35024766
Review.
Glucocorticoids promote
breast
cancer
metastasis.
Milan M S Obradović,
Baptiste Hamelin,
+8 authors,
Nenad Manevski,
Joana Pinto Couto,
Atul Sethi,
Marie-May Coissieux,
Simone Münst,
Ryoko Okamoto,
Hubertus Kohler,
Alexander Schmidt,
Mohamed Bentires-Alj.
less
Nature. 2019 Mar 13; 567(7749):540-544. PMID: 30867597
Highly Cited.
Relevance of tumor-infiltrating lymphocytes in
breast
cancer
.
Sathana Dushyanthen,
Paul A Beavis,
+5 authors,
Peter Savas,
Zhi Ling Teo,
Chenhao Zhou,
Mariam Mansour,
Phillip K Darcy,
Sherene Loi.
less
BMC Med. 2015 Aug 24; 13:202. PMID: 26300242
Free PMC article
Highly Cited. Review.
HER2-positive
breast
cancer
: new therapeutic frontiers and overcoming resistance.
Sonia Pernas, Sara M Tolaney.
Ther Adv Med Oncol. 2019 Mar 19; 11:1758835919833519. PMID: 30911337
Free PMC article
Highly Cited. Review.
Immunotherapy and targeted therapy combinations in metastatic
breast
cancer
.
Francisco J Esteva, Vanessa M Hubbard-Lucey, Jun Tang, Lajos Pusztai.
Lancet Oncol. 2019 Mar 08; 20(3):e175-e186. PMID: 30842061
Highly Cited. Review.
Clinical significance of tumor-infiltrating lymphocytes in
breast
cancer
.
Sasha E Stanton, Mary L Disis.
J Immunother Cancer. 2016 Oct 18; 4:59. PMID: 27777769
Free PMC article
Highly Cited. Review.
Risk-reducing mastectomy for the prevention of primary
breast
cancer
.
Nora E Carbine, Liz Lostumbo, Judi Wallace, Henry Ko.
Cochrane Database Syst Rev. 2018 Apr 05; 4:CD002748. PMID: 29620792
Free PMC article
Highly Cited. Systematic Review. Review.
Previous
1
2
3
4
5
6
7
8
9
10
Next